Click here to receive MS news via e-mail
Posted: Jul 19, 2017 4:03 AM EDT
trials, has shown medical benefit. CBD is being studied for a number of chronic conditions, including multiple sclerosis, due to its potential anti spastic properties. CBD is unlike THC, the component of the marijuana plant that makes people “high.”The fact is that MMJ Bio Science is utilizing a purified pharmaceutical formulation of plant-derived CBD is of particular importance as MMJ BioScience’s formulation is expected to be an indicated use in adults patients with MS.
Pharmaceutical CBD is a consistent, standardized formulation of CBD that meets chemical purity and quality measures and is studied in randomized, controlled clinical trials with oversight from a recognized regulatory authority, such as the U.S. Food and Drug Administration (FDA) to ensure safety and efficacy. To date, there are no plant-derived THC & CBD products that meet FDA standards.